Ben Marsh

• The underwriters of PACS Group’s $690 million primary and secondary follow on offering of common stock
• The agent in Inotiv’s $50 million at-the-market offering of common stock
• The underwriters of Taysha Gene Therapies’ $75 million follow-on public offering of common stock and pre-funded warrants
• The underwriters of Royalty Pharma’s $1.5 billion senior unsecured notes offering
• The underwriters of PACS Group’s $517 million Initial Public Offering of common stock
• The underwriters of KalVista Pharmaceuticals’ $160 million follow-on public offering of common stock and pre-funded warrants
• The agents in Silence Therapeutics’ $120 million private placement (PIPE) of American Depositary Shares
• Orchard Therapeutics in its $478 million acquisition by Kyowa Kirin
• The underwriters of Myriad Genetics’ $127 million follow-on public offering of common stock
• The initial purchasers of Enovis Corporation’s $460 million 3.875% convertible senior notes offering
• The initial purchasers of Amphastar Pharmaceuticals’ $345 million 2.00% convertible senior notes offering
• COMPASS Pathways in an up to $285 million private placement (PIPE) of American Depositary Shares and warrants to purchase American Depositary Shares 
• The agent in Taysha Gene Therapies’ $150 million private placement (PIPE) of common stock and pre-funded warrants
• The underwriters of CorMedix Inc.’s $40 million follow-on offering of common stock and pre-funded warrants
• Karuna Therapeutics in its $400 million at-the-market (ATM) offering of common stock
• The initial purchasers of Zynex Inc.’s $60 million convertible senior notes offering
• The underwriters of Silence Therapeutics’ $56 million follow-on offering of American Depositary Shares
• Orchard Therapeutics in its up to $188 million private placement (PIPE) strategic financing transaction of ordinary shares and warrants
• The underwriters in multiple secondary follow-on public offerings of Privia Health Group shares totaling over $1.2 billion
• The agents in connection with the tax-free distribution of Ligand Pharmaceutical’s OmniAb antibody discovery business and the business combination of OmniAb Inc. with Avista Public Acquisition Corp. II and related deSPAC transaction
• The agent of Ligand Pharmaceutical’s $100 million at-the-market offering
• Amylyx Pharmaceuticals in its $190 million initial public offering and in its subsequent $246 million follow on public offering
• The agent of Calliditas Therapeutics’ $75 million at-the-market offering of American Depositary Shares
• Amylyx Pharmaceuticals in its $190 million initial public offering
• The underwriters of Bionomics’ $23 million initial public offering of American Depositary Shares
• The agent of Silence Therapeutics’ $100 million at-the-market offering of American Depositary Shares
• COMPASS Pathways in its $144 million follow-on public offering of American Depositary Shares and $150 million at-the-market offering of American Depositary Shares
• The agent of VBI Vaccines’ $125 million at-the-market offering
• The initial purchasers of Dynavax’s $200 million convertible senior notes offering
• The underwriters of Privia Health Group’s $608 million initial public offering, inclusive of a $92 million concurrent private investment by Anthem, Inc.
• Orchard Therapeutics in its $150 million PIPE transaction
• The underwriters of BeyondSpring’s $86 million, $30 million and $25 million follow-on public offerings
• The underwriters of Royalty Pharma’s $2.5 billion initial public offering and $728 million follow-on public offering
• COMPASS Pathways in its $147 million initial public offering
• The initial purchasers of Royalty Pharma’s $6 billion and $1.3 billion senior unsecured notes offerings
• Checkmate Pharmaceuticals in its $75 million initial public offering and $50 million at-the-market offering
• The underwriters of ACell Inc’s initial public offering (withdrawn)
• The underwriters of Agile Therapeutics’ $45 million follow-on public offering
• argenx SE in its $557 million follow-on public offering
• The underwriters of eHealth’s $227 million follow-on public offering and $130 million inaugural follow-on public offering*
• BeiGene in its $900 million global public offering*
• ConforMIS’ $155 million initial public offering*
• ProQr Therapeutics’ $112 million initial public offering*
• Vascular Biogenics’ $40 million initial public offering*
• Evogene’s $85 million initial public offering*
• Retrophin’s $150 million follow-on public offering*
• AMAG Pharmaceuticals’ $201 million follow-on public offering*
• Sarepta Therapeutics’ $101 million follow-on public offering*
• Syndax Pharmaceuticals’ $53 million initial public offering*

*Denotes experience prior to joining Goodwin.

• The underwriters of Bitdeer Technologies Group’s $172 million convertible senior notes offering
• PTC Inc. in a $827 million secondary block trade of its common stock
• The Underwriters of FTC Solar’s $258 million initial public offering
• SoFi Technologies in its business combination with Social Capital Hedosophia and related deSPAC transaction for a transaction value of $8.65 billion
• Verra Mobility’s $187 million inaugural public offering*
• The Underwriters of GreenSky’s $1.01 billion initial public offering* 
• The Underwriters on multiple follow-on public offerings by Kornit Digital* 
• YuMe’s $46 million initial public offering*
• Trulia’s $117 million initial public offering and $230 million follow-on public offering* 
• ExactTarget’s $186 million initial public offering and $194 million follow-on public offering*
• Ambarella’s $41 million initial public offering*
• Kayak Software’s $105 million initial public offering*
• Bazaarvoice’s $131 million initial public offering and $131 million follow-on public offering*
• LifeLock’s $184 million initial public offering*
• Boingo’s $78 million initial public offering*

*Denotes experience prior to joining Goodwin.

• The underwriters of J. Jill’s $71 million primary and secondary public offering of common stock
• The underwriters of Celsius Holdings’ $462 million follow-on public offering
• Del Frisco’s Restaurant Group’s $75 million initial public offering and $83 million, $147 million and $121 million follow-on public offerings*
• Amira Nature Foods’ $90 million initial public offering*

*Denotes experience prior to joining Goodwin.

• The underwriters of VSE Corporation’s $150 million and $138 million follow-on public offerings
• The underwriters of VSE Corporation’s $138 million follow-on public offering
• The underwriters of Ducummon Incorporated’s $92 million re-IPO
• Advance Disposal Service’s $380 million initial public offering*
• Atkore International Group’s $192 million initial public offering*
• SiteOne Landscape Supply’s $242 million initial public offering*
• Ryerson Holding’s $121 million initial public offering*
• Metaldyne Performance Group’s $172 million initial public offering*
• Colfax Corp.’s $633 million and $509 million follow-on public offerings*
• Constellium’s $376 million initial public offering and $342 million follow-on public offering*
• Armstrong World Industries’ $624 million follow-on public offering* 
• TriMas Corp.’s $37 million follow-on public offering*

*Denotes experience prior to joining Goodwin.

• Tremont Mortgage Trust’s $70 million initial public offering and concurrent private placement*
• Ladder Capital’s $259 million initial public offering and various follow-on equity and debt offerings* 
• Multiple public offerings by NorthStar Realty Finance* 
• Multiple public offerings by Kennedy-Wilson Holdings* 
• Ramco Gershenson Properties Trust’s $150 million and $114 million follow-on public offerings and $150 million at-the-market offering* 
• Strategic Hotels and Resorts’ $115 million follow-on public offering*
• Multiple follow-on public offerings by Armour Residential REIT*
• Boyd Gaming Corp.’s $228 million follow-on public offering*
• Isle of Capri Casinos’ $63 million follow-on public offering*

*Denotes experience prior to joining Goodwin.

• SoFi Technologies in its business combination with Social Capital Hedosophia and related deSPAC transaction for a transaction value of $8.65 billion
• Byline Bancorp’s $145 million initial public offering*
• Eagle Point Credit’s $100 million initial public offering and $25 million follow-on public offering*
• Oxford Lane Capital’s $68 million rights offering and $53 million follow-on public offering*
• Fly Leasing’s $184 million follow-on public offering*
• Solar Senior Capital’s $160 million initial public offering*
• Multiple public offerings by TCP Capital*
• TICC Capital’s $61 million follow-on public offering*

*Denotes experience prior to joining Goodwin.

• Univar’s $886 million initial public offering and concurrent private placement*
• Pioneer Natural Resources’ $951 million follow-on public offering*
• Tallgrass Energy Partners’ $569 million follow-on public offering*
• PBF Energy’s $540 million follow-on public offerings*
• NGL Energy Partners’ $300 million inaugural follow-on public offering*

*Denotes experience prior to joining Goodwin.